{
    "nctId": "NCT01493336",
    "briefTitle": "A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours",
    "officialTitle": "A Randomized, Open-label, Single Dose, Two-way Cross-Over Study to Investigate the Relative Bioavailability of Capecitabine in Rapid Disintegrating Tablets (RDT) Versus the Commercial Xeloda\u00ae Tablets Following Oral Administrations in Adult Patients With Solid Tumours",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Colorectal Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 37,
    "primaryOutcomeMeasure": "Relative bioavailability: Area under the concentration-time curve (AUC)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients,\\>/= 18 years of age\n* Histological/cytological confirmation of colorectal or breast cancer\n* Patient is ambulatory and has a Karnofsky performance status of \\> 70%\n* Body surface area between 1.5 and 2.0 m2\n* Either:\n* Due to receive Xeloda as monotherapy or as combination therapy as per their treating physician's treatment plan, or\n* Currently receiving Xeloda monotherapy and in the investigator's opinion able to tolerate study drug dose on Day 1 and Day 2\n\nExclusion Criteria:\n\n* Any contraindication to Xeloda\n* Received Xeloda in the 6 days prior to Day 1\n* Subjects with organ allografts (other than autologous bone marrow transplant after high dose chemotherapy)\n* Renal impairment\n* Pregnant or lactating females\n* Participation in an investigational drug study within 28 days prior to screening\n* Lack of physical integrity of the upper gastrointestinal tract, or clinically significant malabsorption syndrome\n* Serious uncontrolled intercurrent infections\n* History of clinically significant coronary artery disease\n* Concomitant treatment with warfarin\n* Known dihydropyrimidine dehydrogenase deficiency",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}